To copper-fasten Trinity’s position as a leading international scientific university, Trinity recently opened a 35,000 sq. m. Biomedical Sciences Institute.
The objective of the Institute is to consolidate pre-clinical biomedical science research activities across five schools – Chemistry; Engineering; Biochemistry & Immunology; Medicine; Pharmacy & Pharmaceutical Sciences – achieving the close interdisciplinary collaboration required to drive leading edge 21st Century biomedical research.
The programme of research for this facility builds on Trinity’s recognised expertise in immunology and its integrating role in diseases such as cancer and field of medical device technologies. Three interlinked centres of research have been created: CSI-Dublin: Centre for Study of Immunology; C2D2: Centre for Cancer Drug Discovery; CMDT: Centre for Medical Device Technologies.
Opened in 2011 to coincide with the tercentenary of the School of Medicine, the development houses all pre-clinical medical education and training activities. In a departure for an academic institution, researchers will work alongside industry in dedicated industry-academic collaborative and commercial labspace.
The estimated cost is €131M. Funding secured:
- €55.4M received under the Programme for Research in Third Level Institutions (PRTLI)
- €13.4M from the Higher Education Authority towards the capital costs of medical teaching space
- €3.25M major philanthropic donations
- €200K from alumni of the School of Medicine
Visit the Biomedical Sciences Institute website to find out more about what's going on in the School or email Zhanna O'Clery or contact her by phone on +353 1 896 2088 if you would like to learn more about how you can get involved.